Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Search
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
BI India joins forces with PPAM and BMC to Stop Rabies
This initiative will adopt a two-pronged approach of vaccination and education.
Boehringer Ingelheim India recognized as Top Employer 2024
Boehringer Ingelheim India recognized as Top Employer 2024
Chronic Kidney Disease
Chronic kidney disease affects approximately 850 million people worldwide which is more than ten percent of the population.
About Chronic Kidney Disease
Find out more about chronic kidney disease, it’s causes and symptoms
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease
Jardiance® (empagliflozin) now approved in India
Our Purpose
Find out what 'transforming lives' and 'for generations' means for our work and long-term thinking here. Click here to learn more about our purpose.
We are independent, family-owned
At Boehringer Ingelheim we are independent, family-owned and intend to remain so. Click here to discover how we live our Leitbild and learn more.
A Unique Bond: human and animal health
At Boehringer Ingelheim we are dedicated to animal and human health. We celebrate the truly unique bonds between people and their pets. Learn more here.
Press Releases
Click here to find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news.
Driving Innovation through Diversity & Inclusion
Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work. Learn more here.
Winfrieds Story
Over 60 million people worldwide are affected by heart failure. Listen to Winfried, who has heart failure, speak about the impact of his heartbeat moment.
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
Accessibility Statement
Boehringer Ingelheim prides itself on being accessible to our audience. Click here to see how we are making our website as user friendly as possible.
Our Stories
Boehringer Ingelheim has many initiatives we would like to share. Find out more about us here by reading our press releases, news stories, and more.
CSR Policy 2024
Financials
Financials
Sustainable Development - Our Commitment
View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better.
More Potential
Continuing a journey that began more than 135 years ago, Boehringer Ingelheim steps up its commitment to sustainable development. Find out more here.
Companion Animals
Boehringer Ingelheim Animal Health helps provide longer, healthier and happier lives for companion animals. Click here to learn and find out more.
Imprint
Here you can access contact details and information about Boehringer Ingelheim International GmbH. Click here to find out and learn more information.
Patient Centricity
At Boehringer Ingelheim, we put patients first in everything we do. Click here to learn more about patient centricity at Boehringer Ingelheim.
Ethics and Compliance
Find out about our ethical and compliance standards here. Access and view our Speak Up Policy, EFPIA disclosure, and Supplier Code of Conduct.
More Green
Our MORE GREEN pillar encompasses environmental initiatives that consider many different aspects. Click here to learn more about our MORE GREEN pillar.